Company Filing History:
Years Active: 2022-2024
Title: Sean Christopher Daugherty: Innovator in Genetic Therapeutics
Introduction
Sean Christopher Daugherty is a notable inventor based in Petaluma, CA (US). He has made significant contributions to the field of genetic therapeutics, holding 2 patents that focus on innovative treatments for metabolic disorders.
Latest Patents
Daugherty's latest patents include "Compositions and methods for treating phenylketonuria." This invention provides a range of translatable polynucleotide and oligomer molecules for expressing a human phenylalanine hydroxylase (PAH), or a fragment thereof having PAH activity. The polynucleotide and oligomer molecules are expressible to provide the human PAH or a fragment thereof having PAH activity. These molecules can be used as active agents to express an active polypeptide or protein in cells or subjects. The agents can be utilized in methods for ameliorating, preventing, delaying onset, or treating a disease or condition associated with phenylketonuria, decreased metabolism of phenylalanine, or increased levels of phenylalanine in a subject. Another significant patent is for "Therapeutics for glycogen storage disease type III." This invention also provides a range of translatable polynucleotide and oligomer molecules for expressing a human amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), or a fragment thereof having AGL activity. The polynucleotide and oligomer molecules are expressible to provide the human AGL or a fragment thereof having AGL activity. These molecules can be used as active agents to express an active polypeptide or protein in cells or subjects, aiding in methods for ameliorating, preventing, delaying onset, or treating a disease or condition associated with reduced activity of AGL in a subject.
Career Highlights
Throughout his career, Daugherty has worked with prominent companies in the biotechnology sector, including Arcturus Therapeutics, Inc. and Ultragenyx Pharmaceutical Inc. His work has focused on developing innovative solutions for complex genetic disorders.
Collaborations
Daugherty has collaborated with notable professionals in his field, including Kiyoshi Tachikawa and Carlos Gustavo Perez-Garcia. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion